BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33234629)

  • 1. Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants.
    McQueenie R; Nicholl BI; Jani BD; Canning J; Macdonald S; McCowan C; Neary J; Browne S; Mair FS; Siebert S
    BMJ Open; 2020 Nov; 10(11):e038829. PubMed ID: 33234629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between risk, duration and cause of hospitalisations in people with rheumatoid arthritis and multimorbidity in the UK Biobank and Scottish Early Rheumatoid Arthritis (SERA) cohorts: Longitudinal observational study.
    Morton FR; Jani BD; Mair FS; McLoone P; Canning J; Macdonald S; McQueenie R; Siebert S; Nicholl BI
    Semin Arthritis Rheum; 2023 Feb; 58():152130. PubMed ID: 36459724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
    Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
    PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort.
    Jani BD; Hanlon P; Nicholl BI; McQueenie R; Gallacher KI; Lee D; Mair FS
    BMC Med; 2019 Apr; 17(1):74. PubMed ID: 30967141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of long-term condition patterns in rheumatoid arthritis and associations with adverse health events: a UK Biobank cohort study.
    McLoone P; Jani BD; Siebert S; Morton FR; Canning J; Macdonald S; Mair FS; Nicholl BI
    J Multimorb Comorb; 2023; 13():26335565221148616. PubMed ID: 36798088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimorbidity in a selected cohort compared to a representative sample: Does selection bias influence outcomes?
    Hanlon P; Bhautesh J; Mair F; McAllister D
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
    McQueenie R; Foster HME; Jani BD; Katikireddi SV; Sattar N; Pell JP; Ho FK; Niedzwiedz CL; Hastie CE; Anderson J; Mark PB; Sullivan M; O'Donnell CA; Mair FS; Nicholl BI
    PLoS One; 2020; 15(8):e0238091. PubMed ID: 32817712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort.
    Jani BD; Nicholl BI; McQueenie R; Connelly DT; Hanlon P; Gallacher KI; Lee D; Mair FS
    Europace; 2018 Nov; 20(FI_3):f329-f336. PubMed ID: 29112751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort.
    Corcoran NM; Mair FS; Nicholl B; Macdonald S; Jani BD
    J Multimorb Comorb; 2022; 12():26335565221110123. PubMed ID: 36132374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants.
    Dodds RM; Granic A; Robinson SM; Sayer AA
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):62-68. PubMed ID: 31886632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frailty in rheumatoidrmdopen-2021-002111 arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank.
    Hanlon P; Morton F; Siebert S; Jani BD; Nicholl BI; Lewsey J; McAllister D; Mair FS
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35292529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between multimorbidity status and incident dementia: a prospective cohort study of 245,483 participants.
    Hu HY; Zhang YR; Aerqin Q; Ou YN; Wang ZT; Cheng W; Feng JF; Tan L; Yu JT
    Transl Psychiatry; 2022 Dec; 12(1):505. PubMed ID: 36476644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank.
    McQueenie R; Jani BD; Siebert S; McLoone P; McCowan C; Macdonald S; Mair FS; Nicholl BI
    J Multimorb Comorb; 2021; 11():26335565211005870. PubMed ID: 35004337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort.
    Sullivan MK; Jani BD; Lees JS; Welsh CE; McConnachie A; Stanley B; Welsh P; Nicholl BI; Lyall DM; Carrero JJ; Nitsch D; Sattar N; Mair FS; Mark PB
    Clin Kidney J; 2021 Nov; 14(11):2409-2419. PubMed ID: 34754437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
    Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
    PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term conditions, multimorbidity, lifestyle factors and change in grip strength over 9 years of follow-up: Findings from 44,315 UK biobank participants.
    Hurst C; Murray JC; Granic A; Hillman SJ; Cooper R; Sayer AA; Robinson SM; Dodds RM
    Age Ageing; 2021 Nov; 50(6):2222-2229. PubMed ID: 34657960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
    Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
    Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study.
    Chudasama YV; Khunti K; Gillies CL; Dhalwani NN; Davies MJ; Yates T; Zaccardi F
    PLoS Med; 2020 Sep; 17(9):e1003332. PubMed ID: 32960883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings.
    Sullivan MK; Jani BD; McConnachie A; Hanlon P; McLoone P; Nicholl BI; Carrero JJ; Nitsch D; McAllister D; Mair FS; Mark PB
    BMC Med; 2021 Nov; 19(1):278. PubMed ID: 34794437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom.
    Bisquera A; Turner EB; Ledwaba-Chapman L; Dunbar-Rees R; Hafezparast N; Gulliford M; Durbaba S; Soley-Bori M; Fox-Rushby J; Dodhia H; Ashworth M; Wang Y
    Lancet Reg Health Eur; 2022 Jan; 12():100247. PubMed ID: 34901910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.